Articles

Why this stock-market wizard is 100% invested in the S&P 500 right now — even after the U.S. strike on Iran

Mark Minervini shares what’s worked for him over his long trading career and talks about how to invest in the stock market now.

Trump Media’s ‘DJT’ stock jumps, as planned buybacks could cut share count by 10%

Trump Media, the parent of President Donald Trump’s social-media platform Truth Social, announced a $400 million stock-repurchase program, which could reduce the number of shares outstanding by 10%.

Tesla owners can make money by turning their cars into robotaxis, Elon Musk says. This is how it would work.

Tesla’s stock shot higher after Sunday’s launch of the EV maker’s eagerly anticipated — and recently delayed — robotaxi service in Austin, Texas.

Here’s why these analysts see ‘a lot more to go’ for AMD’s stock in the next few years

Melius analysts expect more AI-chip sales as demand grows for running AI models and for AMD’s new offerings to attract hyperscaler and sovereign customers.

20 oil stocks passing a quality screen as investors wonder what Iran will do next

Nobody knows how badly the international oil market might be disrupted by Iran. But if you want to take advantage of the uncertainty, a screen encompassing debt levels and cash flow can limit your risk.

Businesses face rising inflation due to tariffs. Will consumers get hit next?

The cost of doing business for U.S. companies rose in June at the second-fastest pace in two and a half years, a pair of S&P surveys showed, reflecting ongoing inflation pressures tied to high Trump administration tariffs.

Home sales remain sluggish as some ‘stubborn sellers’ refuse to give in on price

Sales of existing homes inched up slightly in May but remained depressed as buyers shied away from a housing market that features painfully high interest rates and home prices.

Hims & Hers’ stock plunges. Here’s why Wegovy parent ended its partnership with the company.

Hims & Hers Health Inc.’s stock fell sharply on Monday after pharmaceutical giant Novo Nordisk, maker of the weight-loss drug Wegovy, said it was ending a collaboration with the telehealth-consultation company less than two months after it started.

These are the areas where markets are complacent and risks lurk

A report by Deutsche Bank highlights where pricing is strange in markets.

Fiserv’s stock surges as it teams with Circle to join the stablecoin party

An analyst issues bullish $421 price target for Coinbase’s stock, while Fiserv’s stock moves up as stablecoin products roll out.

Here’s how to ditch your restrictive 401(k) plan and pick your own investments

If you’re worried about this move being too risky, wait until you see the top asset of those already using a 401(k) brokerage window.

‘I’m 49 and have no debt except for a mortgage’: Should I take a $61,000 lump sum or $355 a month for life?

“My S&P 500 investments have roughly doubled every seven years.”
1 308 309 310 311 312 2,445